National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

emtricitabine
A synthetic nucleoside analogue of cytidine with activity against human immunodeficiency virus type 1 reverse transcriptase (RT). Emtricitabine is phosphorylated by cellular enzymes to form emtricitabine 5'-triphosphate. Emtricitabine 5'-triphosphate inhibits the activity of HIV-1 RT by competing with the RT natural substrate deoxycytidine 5'-triphosphate and by being incoprorated into nascent viral DNA which results in the termination of viral DNA chain elongation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Coviracil
FTC
US brand name:Emtriva
Chemical structure names:
  • (-)-2'-Deoxy-5-fluoro-3'-thiacytidine
  • 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-,(2R-cis)-



Previous:Elspar, eltrombopag olamine, Emcyt, Emend, Empirin
Next:Emtriva, Enbrel, enclomiphene citrate, endothelin B receptor agonist SPI-1620, Enhanzyn

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov